Skip to main content
GoodMoatv1.3
Sign in
TEVA logo

TEVA

CompareEarnings: Aug 31, 2026

Teva- Pharmaceutical Industries Ltd

Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products.

Current Price

$35.73

-0.78%

GoodMoat Value

$21.98

38.5% overvalued
Profile
Valuation (TTM)
Market Cap$41.08B
P/E26.27
EV—
P/B5.19
Shares Out1.15B
P/Sales2.37
Revenue$17.35B
EV/EBITDA16.43

Teva- Pharmaceutical Industries Ltd (TEVA) Company Profile

TEVA Company Information

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century.

We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area.

Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry.

Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NYSE

Country

Israel

TEVA Key Officers

Key officers data coming soon

TEVA Company Profile

Teva- Pharmaceutical Industries Ltd (TEVA) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. It trades on NYSE. The company is based in Israel.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products.

Market cap is $41.08B. There are 1149.8M shares outstanding.

See the full Teva- Pharmaceutical Industries Ltd profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if TEVA is a good investment.